1,026
Participants
Start Date
October 31, 2011
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
Rimegepant
Rimegepant capsules
Placebo
Rimegepant placebo-matching capsules
Sumatriptan
Rimegepant matching sumatriptan and Rimegepant matching placebo capsules
Central New York Clinical Research, Manlius
Regional Clinical Research Inc., Endwell
Rochester Clinical Research, Inc., Rochester
Thomas Jefferson University, Philadelphia
Clinical Research Of Philadelphia, Llc, Philadelphia
The Innovative Clinical Research Center, Alexandria
Tidewater Integrated Medical Research, Virginia Beach
Pmg Research Of Winston-Salem, Winston-Salem
Pharmquest, Greensboro
Wake Research Associates, Raleigh
Coastal Carolina Research Center, Inc., Mt. Pleasant
Compass Research, Llc, Orlando
Broward Research Group, Pembroke Pines
Miami Research Associates, Miami
Comprehensive Clinical Development, Inc, St. Petersburg
Renstar Medical Research, Ocala
Clinsearch, Llc, Chattanooga
Cleveland Clinic, Cleveland
Community Research, Cincinnati
Michigan Head Pain And Neurological Institute, Ann Arbor
Clinical Research Institute, Inc., Minneapolis
Diamond Headache Clinic, Ltd., Chicago
Mercy Health Research, St Louis
The Center For Pharmaceutical Research. Pc, Kansas City
Clinvest/ A Division Of Banyan Group, Inc., Springfield
R/D Clinical Research, Inc., Lake Jackson
Premier Research Group Limited, Austin
Futuresearch Trials Of Neurology, Austin
Radiant Research, Inc., Denver
J. Lewis Research, Inc, Salt Lake City
J. Lewis Research, Inc, Salt Lake City
Mayo Clinic Arizona, Scottsdale
Clinical Res. Advantage Inc/ Desert Clinical Research Llc, Tempe
California Medical Clinic For Headache, Santa Monica
Encompass Clinical Research, Spring Valley
University Of California, San Francisco, San Francisco
Diablo Clinical Research, Inc., Walnut Creek
Swedish Pain And Headache Center, Seattle
Milford Emergency Associates, Inc., Milford
Medvadis Research Corporation, Watertown
Omega Medical Research, Warwick
Lead Sponsor
Pfizer
INDUSTRY